MetaADEDB 2.0 @ LMMD
Brimonidine Tartrate, Timolol Maleate Drug Combination
(ZUIFJYRNWWNOPB-PPHPATTJSA-N)
Structure
SMILES
Brc1c(ccc2c1nccn2)NC1=NCCN1.O[C@H](COc1nsnc1N1CCOCC1)CNC(C)(C)C
Molecular Formula:
C24H34BrN9O3S
Molecular Weight:
608.554
Log P:
2.5592
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
4
TPSA:
170.18
CAS Number(s):
952743-07-6
Synonym(s)
1.
Brimonidine Tartrate, Timolol Maleate Drug Combination
2.
Brimonidine Tartrate-Timolol Maleate
3.
Brimonidine Tartrate-Timolol Maleate Drug Combination
4.
Combigan
5.
Brimonidine Tartrate Timolol Maleate
6.
Brimonidine Tartrate Timolol Maleate Drug Combination
7.
Maleate, Brimonidine Tartrate-Timolol
8.
Tartrate-Timolol Maleate, Brimonidine
External Link(s)
MeSHD000068599
PubChem Compound11387895
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 118
Canada Vigilance: 2
Canada Vigilance
US FAERS
2Eye painFAERS: 75
Canada Vigilance: 3
Canada Vigilance
US FAERS
3DizzinessFAERS: 55
Canada Vigilance: 4
Canada Vigilance
US FAERS
4HypersensitivityFAERS: 38US FAERS
5FatigueFAERS: 36
Canada Vigilance: 3
Canada Vigilance
US FAERS
6Drug ineffectiveFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
7AstheniaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
8Accidental exposure to productFAERS: 22US FAERS
9Product dose omissionFAERS: 21US FAERS
10Visual ImpairmentFAERS: 20US FAERS
11HeadacheFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
12SomnolenceFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Foreign body sensation in eyesFAERS: 18US FAERS
14Inappropriate schedule of drug administrationFAERS: 18US FAERS
15ErythemaFAERS: 15US FAERS
16Product container issueFAERS: 15US FAERS
17GlaucomaFAERS: 14US FAERS
18Incorrect dose administeredFAERS: 14US FAERS
19Product storage errorFAERS: 14US FAERS
20BlepharitisFAERS: 13US FAERS
21HypotensionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
22PruritusFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Drug dose omissionFAERS: 12US FAERS
24Inappropriate schedule of product administrationFAERS: 11US FAERS
25MalaiseFAERS: 11US FAERS
26Eye InfectionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Feeling abnormalFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
28BradycardiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
29CataractFAERS: 9US FAERS
30Chest discomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
31PhotophobiaFAERS: 9US FAERS
32Eye inflammationFAERS: 8US FAERS
33PalpitationsFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Product packaging quantity issueFAERS: 8US FAERS
35Product quality issueFAERS: 8US FAERS
36AlopeciaFAERS: 7US FAERS
37ArthralgiaFAERS: 7US FAERS
38Burning sensationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Cerebrovascular accidentFAERS: 7US FAERS
40Chest PainFAERS: 7US FAERS
41Eyelid exfoliationFAERS: 7US FAERS
42Eyelid irritationFAERS: 7US FAERS
43IritisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Product dropper issueFAERS: 7US FAERS
45ConjunctivitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
46DysgeusiaFAERS: 6US FAERS
47Eyelid margin crustingFAERS: 6US FAERS
48Eyelids pruritusFAERS: 6US FAERS
49IridocyclitisFAERS: 6US FAERS
50Memory impairmentFAERS: 6US FAERS
51PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
52UrticariaFAERS: 6US FAERS
53Wrong technique in product usage processFAERS: 6US FAERS
54Abdominal discomfortFAERS: 5US FAERS
55AsthmaFAERS: 5US FAERS
56Dry skinFAERS: 5US FAERS
57EpistaxisFAERS: 5US FAERS
58Joint swellingFAERS: 5US FAERS
59Ocular discomfortFAERS: 5US FAERS
60Counterfeit drug administeredFAERS: 4US FAERS
61DermatitisFAERS: 4US FAERS
62FlushingFAERS: 4US FAERS
63Lip swellingFAERS: 4US FAERS
64Macular degenerationFAERS: 4US FAERS
65Myocardial InfarctionFAERS: 4US FAERS
66Oropharyngeal painFAERS: 4US FAERS
67Poor quality drug administeredFAERS: 4US FAERS
68Retinal DetachmentFAERS: 4US FAERS
69Sinus bradycardiaFAERS: 4US FAERS
70Skin irritationFAERS: 4US FAERS
71SneezingFAERS: 4US FAERS
72UveitisFAERS: 4US FAERS
73VomitingFAERS: 4US FAERS
74Adverse eventFAERS: 3US FAERS
75AsthenopiaFAERS: 3US FAERS
76Atrial FibrillationFAERS: 3US FAERS
77Diabetes MellitusFAERS: 3US FAERS
78DiplopiaFAERS: 3US FAERS
79DisorientationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Eye allergyFAERS: 3US FAERS
81Eyelid painFAERS: 3US FAERS
82Instillation site painFAERS: 3US FAERS
83Nasal discomfortFAERS: 3US FAERS
84NauseaFAERS: 3US FAERS
85NervousnessFAERS: 3US FAERS
86Peripheral swellingFAERS: 3US FAERS
87ScabFAERS: 3US FAERS
88SyncopeFAERS: 3US FAERS
89TinnitusFAERS: 3US FAERS
90Activities of daily living impairedFAERS: 2US FAERS
91Allergic bronchitisFAERS: 2US FAERS
92AmnesiaFAERS: 2US FAERS
93Back PainFAERS: 2US FAERS
94BlindnessFAERS: 2US FAERS
95BronchitisFAERS: 2US FAERS
96Cataract operationFAERS: 2US FAERS
97ChokingFAERS: 2US FAERS
98Dark circles under eyesFAERS: 2US FAERS
99DiscomfortFAERS: 2US FAERS
100Drug administration errorFAERS: 2US FAERS
101Drug toxicityFAERS: 2US FAERS
102Erectile dysfunctionFAERS: 2US FAERS
103Excessive eye blinkingFAERS: 2US FAERS
104Eyelid rashFAERS: 2US FAERS
105Growth of eyelashesFAERS: 2US FAERS
106Intraocular pressure fluctuationFAERS: 2US FAERS
107Intraocular pressure test abnormalFAERS: 2US FAERS
108Joint stiffnessFAERS: 2US FAERS
109LacerationFAERS: 2US FAERS
110LethargyFAERS: 2US FAERS
111Muscle strainFAERS: 2US FAERS
112MydriasisFAERS: 2US FAERS
113NasopharyngitisFAERS: 2US FAERS
114No adverse eventFAERS: 2US FAERS
115PallorFAERS: 2US FAERS
116Poor quality product administeredFAERS: 2US FAERS
117Product complaintFAERS: 2US FAERS
118Product contaminationFAERS: 2US FAERS
119Product dispensing errorFAERS: 2US FAERS
120Product size issueFAERS: 2US FAERS
121Rash erythematousFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
122Skin UlcerFAERS: 2US FAERS
123Skin lesionFAERS: 2US FAERS
124SomnambulismFAERS: 2US FAERS
125VertigoFAERS: 2US FAERS
126Weight decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Wrong drug administeredFAERS: 2US FAERS
128Abdominal PainFAERS: 1US FAERS
129Accidental overdoseFAERS: 1US FAERS
130AcneFAERS: 1US FAERS
131Ankle FractureFAERS: 1US FAERS
132AnosmiaFAERS: 1US FAERS
133AnxietyFAERS: 1US FAERS
134ArthritisFAERS: 1US FAERS
135BlepharopachynsisFAERS: 1US FAERS
136BlepharospasmFAERS: 1US FAERS
137Blood glucose abnormalFAERS: 1US FAERS
138Blood glucose increasedFAERS: 1US FAERS
139Bone painFAERS: 1US FAERS
140BradyphreniaFAERS: 1US FAERS
141Cardiac FlutterFAERS: 1US FAERS
142ChromaturiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
143DeafnessFAERS: 1US FAERS
144Deep Vein ThrombosisFAERS: 1US FAERS
145DehydrationFAERS: 1US FAERS
146Depressed moodFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
147Device malfunctionFAERS: 1US FAERS
148Documented hypersensitivity to administered drugFAERS: 1US FAERS
149Drug administered at inappropriate siteFAERS: 1US FAERS
150Drug ineffective for unapproved indicationFAERS: 1US FAERS
151Drug prescribing errorFAERS: 1US FAERS
152DysarthriaFAERS: 1US FAERS
153Ear discomfortFAERS: 1US FAERS
154EcchymosisFAERS: 1US FAERS
155EczemaFAERS: 1US FAERS
156EosinophiliaFAERS: 1US FAERS
157Epigastric discomfortFAERS: 1US FAERS
158Excessive skinFAERS: 1US FAERS
159ExcoriationFAERS: 1US FAERS
160Exfoliative rashFAERS: 1US FAERS
161Expired drug administeredFAERS: 1US FAERS
162Expired product administeredFAERS: 1US FAERS
163Extremity necrosisFAERS: 1US FAERS
164Eye BurnsFAERS: 1US FAERS
165Eye laser surgeryFAERS: 1US FAERS
166Eye operation complicationFAERS: 1US FAERS
167Eyelid Function DisorderFAERS: 1US FAERS
168Facial PainFAERS: 1US FAERS
169FolliculitisFAERS: 1US FAERS
170FrostbiteFAERS: 1US FAERS
171GoutFAERS: 1US FAERS
172Head discomfortFAERS: 1US FAERS
173HordeolumFAERS: 1US FAERS
174HydrocephalusFAERS: 1US FAERS
175HypersomniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
176HypogeusiaFAERS: 1US FAERS
177IncontinenceFAERS: 1US FAERS
178Incorrect dose administered by productFAERS: 1US FAERS
179Incorrect product storageFAERS: 1US FAERS
180Incorrect route of drug administrationFAERS: 1US FAERS
181Incorrect storage of drugFAERS: 1US FAERS
182InfectionFAERS: 1US FAERS
183InflammationFAERS: 1US FAERS
184InfluenzaFAERS: 1US FAERS
185Intentional dose omissionFAERS: 1US FAERS
186Intentional product misuseFAERS: 1US FAERS
187Joint injuryFAERS: 1US FAERS
188KeratitisFAERS: 1US FAERS
189Lens dislocationFAERS: 1US FAERS
190Limb injuryFAERS: 1US FAERS
191Lower respiratory tract infectionFAERS: 1US FAERS
192Medical device removalFAERS: 1US FAERS
193Medication residue presentFAERS: 1US FAERS
194MetamorphopsiaFAERS: 1US FAERS
195Mood swingsFAERS: 1US FAERS
196Musculoskeletal PainFAERS: 1US FAERS
197Musculoskeletal stiffnessFAERS: 1US FAERS
198MyopiaFAERS: 1US FAERS
199Neck PainFAERS: 1US FAERS
200Ocular vascular disorderFAERS: 1US FAERS
201Pain of skinFAERS: 1US FAERS
202PneumoniaFAERS: 1US FAERS
203Product label issueFAERS: 1US FAERS
204Product physical issueFAERS: 1US FAERS
205Product use complaintFAERS: 1US FAERS
206Product use issueFAERS: 1US FAERS
207Productive CoughFAERS: 1US FAERS
208Quality of life decreasedFAERS: 1US FAERS
209Renal massFAERS: 1US FAERS
210Respiratory tract congestionFAERS: 1US FAERS
211Retinal Vascular DisorderFAERS: 1US FAERS
212Rheumatoid ArthritisFAERS: 1US FAERS
213Skin ErosionFAERS: 1US FAERS
214Skin necrosisFAERS: 1US FAERS
215Skin reactionFAERS: 1US FAERS
216SwellingFAERS: 1US FAERS
217TachycardiaFAERS: 1US FAERS
218Therapeutic product effect decreasedFAERS: 1US FAERS
219ThirstFAERS: 1US FAERS
220Throat irritationFAERS: 1US FAERS
221Tongue blisteringFAERS: 1US FAERS
222Traumatic fractureFAERS: 1US FAERS
223TremorFAERS: 1US FAERS
224Unevaluable eventFAERS: 1US FAERS
225Urinary IncontinenceFAERS: 1US FAERS
226Urinary tract infectionFAERS: 1US FAERS
227Visual disturbanceFAERS: 1US FAERS
228Vitreous floatersFAERS: 1US FAERS
229Vulvovaginal mycotic infectionFAERS: 1US FAERS
230WheezingFAERS: 1US FAERS
231Wrong technique in drug usage processFAERS: 1US FAERS
232Abnormal sleep-related eventCanada Vigilance: 1Canada Vigilance
233Feeling ColdCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.